Table 2. Cancer distribution in the whole cohort grouped by ICD-10 in the patients with (positive) and without (negative) active BAT.
ICD-10 | BAT-NEG. | BAT-POS. | |||
---|---|---|---|---|---|
N | 7447 | 100% | 460 | 100% | |
C50 | Breast | 736 | 9.9% | 73 | 15.9% |
C34 | Lung | 1358 | 18.2% | 61 | 13.3% |
C43 | Melanoma | 808 | 10.9% | 48 | 10.4% |
C81 | Hodgkin | 334 | 4.5% | 45 | 9.8% |
C18 | Colon | 422 | 5.7% | 21 | 4.6% |
C85 | Non-Hodgkin Lymphoma | 268 | 3.6% | 20 | 4.3% |
C80 | Unknown Primary | 369 | 5% | 19 | 4.1% |
C62 | Testicular | 88 | 1.2% | 18 | 3.9% |
C82 | Follicular Lymphoma | 301 | 4% | 16 | 3.5% |
C53 | Cervix Uteri | 63 | 0.8% | 15 | 3.3% |
C49 | Soft tissue | 64 | 0.9% | 9 | 2% |
C73 | Thyroid | 74 | 1% | 8 | 1.7% |
C01 | Tongue base | 160 | 2.1% | 7 | 1.5% |
C16 | Stomach | 140 | 1.9% | 7 | 1.5% |
C09 | Tonsils | 113 | 1.5% | 6 | 1.3% |
C15 | Esophagus | 280 | 3.8% | 6 | 1.3% |
C20 | Rectum | 93 | 1.2% | 6 | 1.3% |
C25 | Pancreas | 161 | 2.2% | 6 | 1.3% |
C41 | Bone/Cartilage | 24 | 0.3% | 6 | 1.3% |
C21 | Anus | 41 | 0.6% | 4 | 0.9% |
C22 | Liver | 147 | 2% | 4 | 0.9% |
C45 | Mesothelioma | 93 | 1.2% | 4 | 0.9% |
C56 | Ovary | 78 | 1% | 4 | 0.9% |
C10 | Mesopharynx | 114 | 1.5% | 3 | 0.7% |
C02 | Tongue | 54 | 0.7% | 2 | 0.4% |